In-Vitro Lung Model Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the In-Vitro Lung Model Market?
Over recent years, there has been a significant expansion in the market size of the in-vitro lung model. It's projected to increase from $0.44 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of 21.3%. The substantial growth during the previous period can be linked to the rising occurrence of respiratory diseases and increased focus on personalized medical treatments. The growing interest in rediscovering uses for existing drugs, focusing on precision medicine techniques, and heightened consciousness about environmental health risks also contribute to this market expansion.

The market for in-vitro lung models is predicted to witness a significant increase in the coming years. The estimated value by 2029 is about $1.16 billion, propelled by a compound annual growth rate (CAGR) of 21.0%. The expansion during the forecast period could be as a result of the demands for new drug development, the escalation in preliminary trials, growing cognizance of respiratory toxicology, emphasis on regenerative medicine, environmental concerns, and the booming senior citizen population. Furthermore, the projected growth period will likely see an escalated requirement for drug testing, breakthroughs in 3D printing technology, organ-on-chip technology advancements, infusing Artificial Intelligence and machine learning, incorporation of sensors and monitoring devices, extending applications beyond the realm of pharmaceuticals and design of disease-specific models.

What Is Driving the Growth Trajectory of the In-Vitro Lung Model Market?
The in vitro lung model market is predicted to grow due to an uptick in clinical studies. These research studies aim to evaluate the effectiveness of new medical methods on human subjects. The growth in this area is fueled by a greater demand for cutting-edge medical treatments, an escalation in healthcare requirements, and a push for innovative solutions to complicated health problems. In vitro lung models play a useful role in these studies, offering a regulated setting in which to examine the impact of substances on lung tissue, and assist in aspects such as medication testing, toxicity evaluation, disease simulation, and understanding disease processes. For instance, ClinicalTrials.gov, a clinical trial registry based in the US, reported in January 2024 that there were 477,230 clinical trials registered worldwide by the end of 2023. This shows an increase from the 437,508 trials registered in 2022. Consequently, the rise in clinical studies is driving the growth of the in vitro lung model market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Which Businesses Are at the Forefront of In-Vitro Lung Model Market Development?
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Drape*r Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

What Are the Latest Innovations in the In-Vitro Lung Model Market?
Leading entities in the invitro lung model market are innovating 3D respiratory tissue models to increase the physiological relevance and intricacy of their models. These 3D tissue models of the respiratory system are developed by culturing chosen respiratory cells in a unique environment. This process allows the cells to form a three-dimensional structure that emulates the function and morphology of the respiratory system. This structure thus provides a research and drug testing platform that more accurately represents physiological conditions. For example, MatTek Corporation, a biotechnology firm based in the United States, launched EpiNasal, a ground-breaking 3D respiratory tissue model made from primary human nasal epithelial cells in April 2023. EpiNasal replicates the 3D structure and functionality of the nasal epithelium, including tight junctions, goblet cells that produce mucus, and beating cilia. With the introduction of EpiNasal, MatTek has expanded its suite of 3D respiratory tissue models. This new model offers a comprehensive system for investigating the impact of drugs, chemicals, pathogens, and consumer products on the human respiratory system.

How Is the In-Vitro Lung Model Market Segmented?
The in-vitro lung model market covered in this report is segmented -

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:
1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures
2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Where Is the In-Vitro Lung Model Market Growth Most Prominent?
North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The In-Vitro Lung Model Global Market Report?

- Market Size Analysis: Analyze the In-Vitro Lung Model Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the In-Vitro Lung Model Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall In-Vitro Lung Model Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the In-Vitro Lung Model Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.